Antineoplastic cancer treatment prior authorization prohibition

This bill prohibits health insurance companies in Minnesota from requiring prior authorization for antineoplastic cancer treatments that follow National Comprehensive Cancer Network guidelines, directly affecting cancer patients and insurers. It specifically bans prior approval for non-medication cancer treatments (like certain therapies or procedures), while medications for these treatments still require prior authorization but must be processed under faster timelines. The change applies to health benefit plans offered, sold, or renewed on or after January 1, 2027. This eliminates administrative delays for covered cancer treatments, streamlining access to care without altering coverage for medication-based treatments.